MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

IMAB I-MAB Forecast, Technical & Fundamental Analysis

a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

Industry Biotechnology
IMAB
Setup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For IMAB
(Try 14 days for $1 only)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IMAB
Setup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For IMAB
(Try 14 days for $1 only)
Ad is loading...
A.I. Advisor
published Earnings

IMAB is expected to report earnings to fall 41.76% to -12 cents per share on November 29

I-MAB IMAB Stock Earnings Reports
Q3'23
Est.
$-0.13
Q1'24
Est.
$-0.22
Q4'23
Beat
by $0.36
Q2'23
Beat
by $0.75
Q1'23
Beat
by $0.14
The last earnings report on May 29 showed earnings per share of -21 cents, meeting the estimate of -21 cents. With 418.13K shares outstanding, the current market capitalization sits at 89.21M.
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
555 West Haiyang Road
Phone
+86 2160578000
Employees
318
Web
https://www.i-mabbiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

IMAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMAB has been loosely correlated with SEER. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IMAB jumps, then SEER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMAB
1D Price
Change %
IMAB100%
-7.08%
SEER - IMAB
35%
Loosely correlated
-0.60%
AURA - IMAB
35%
Loosely correlated
-7.04%
RLAY - IMAB
34%
Loosely correlated
-4.71%
ARQT - IMAB
34%
Loosely correlated
-3.49%
BEAM - IMAB
34%
Loosely correlated
-8.55%
More